Washington Dc, DCNCT07335510Now EnrollingIRB Ready

HFrEF - Heart Failure With Reduced Ejection Fraction Clinical Trial in Washington Dc, DC

Access cutting-edge hfref - heart failure with reduced ejection fraction treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.

Sponsored by Columbia University

Quick Self-Assessment

See if you qualify for this Washington Dc location

Preparing your pre-screening questions…

Expert Care in Washington Dc

Access hfref - heart failure with reduced ejection fraction specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hfref - heart failure with reduced ejection fraction treatment provided free

Apply for This Washington Dc Location

Check if you qualify for this hfref - heart failure with reduced ejection fraction clinical trial in Washington Dc, DC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Washington Dc

    Convenient for DC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Washington Dc site if eligible
  4. 4Begin participation

About This HFrEF - Heart Failure With Reduced Ejection Fraction Study in Washington Dc

This study evaluates the effects of the implantation and adjustment of the CVRx Barostim device in adult patients with heart failure with reduced ejection fraction who are receiving maximally tolerated doses of guideline directed medical and device therapies. The study aims to assess how therapy using this device affects heart function, symptoms, and exercise capacity, with particular focus on how the device affects blood flow and heart pressures during exercise. Information from this study may help inform patient selection and device management in patients with heart failure.

Sponsor: Columbia University

Who Can Participate

Inclusion Criteria

Diagnosis of heart failure with reduced ejection fraction (defined as ejection fraction ≤ 35% for the purposes of this study) (should be within 12 months of screen)
Symptoms consistent with one of:
current New York Heart Association (NYHA) Class III or
current NYHA Class II and historical NYHA Class III
Laboratories with last N-terminal pro-B-type natriuretic peptide (NT-proBNP) \< 1600 pg/ml (should be within 3 months of screen)
Management with maximally-tolerated GDMT medications and devices
Age \>= 18 years

Exclusion Criteria

Age \< 18 years
Myocardial infarction (MI), syncope, cerebrovascular accident (CVA), aborted sudden cardiac death (SCD) (and implantable cardioverter defibrillator (ICD) therapy) within 3 months of screening
Bilateral carotid bifurcations located above the level of the mandible
Carotid artery stenosis greater than 50% caused by atherosclerosis
Ulcerative plaques in the carotid artery
Baroreflex failure or autonomic neuropathy
Symptomatic un-controlled bradyarrhythmias
Severe chronic lung disease
Current treatment with inotropes
Pacemaker or ICD within 3 months of screening
Cardiac resynchronization therapy (CRT) devices within 6 months of screening or anticipated to be placed in the next 90 days following screening
Prior surgery, radiation, endovascular stent in the carotid sinus
History or consideration of solid organ transplantation
History or consideration of left ventricular assist device (LVAD)
Life expectancy \<1 year from time of screening
Non-cardiovascular conditions interfering with 6MWT distance assessment
Inability to fulfill protocol requirements
Known allergy to silicone or titanium

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Washington Dc?

Yes, this clinical trial (NCT07335510) has an active research site in Washington Dc, DC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

HFrEF - Heart Failure With Reduced Ejection Fraction Treatment Options in Washington Dc, DC

If you're searching for hfref - heart failure with reduced ejection fraction treatment options in Washington Dc, DC, this clinical trial (NCT07335510) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hfref - heart failure with reduced ejection fraction specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hfref - heart failure with reduced ejection fraction clinical trials near you to find additional studies recruiting in your area.

More Heart Failure Trials in Washington Dc, DC

See all heart failure clinical trials recruiting in Washington Dc — not just this study.

Browse Heart Failure Trials in Washington Dc →

Browse More Trials by Condition

Heart Failure TrialsRheumatoid Arthritis TrialsUlcerative Colitis TrialsErectile Dysfunction TrialsFanconi Anemia TrialsAll Conditions →

Ready to Join in Washington Dc?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Washington Dc, DC